首页> 外文会议>Conference on vaccine technology VI >EXPISF?: A CHEMICALLY-DEFINED BACULOVIRUS-BASED EXPRESSION SYSTEM FOR ENHANCED PROTEIN PRODUCTION IN SF9 CELLS
【24h】

EXPISF?: A CHEMICALLY-DEFINED BACULOVIRUS-BASED EXPRESSION SYSTEM FOR ENHANCED PROTEIN PRODUCTION IN SF9 CELLS

机译:Expisf ?:一种化学定义的基于杆状病毒的表达系统,用于增强SF9细胞中的蛋白质产生

获取原文

摘要

The Baculovirus Expression Vector System (BEVS) is one of the major platforms for recombinant protein production and the last decade has become a preferred platform for vaccine development. Unlike mammalian expression systems that have long since transitioned to serum-free, chemically-defined culture media, relatively little innovation has taken place in insect expression systems, with insect cells continuing to rely on undefined, yeastolate-containing culture media that can exhibit significant lot-to-lot variability in terms of both cell growth and protein expression. Here, we present the development of a novel Sf9-based Baculovirus expression system based on a high-density, chemically-defined culture medium, a high-expressing Sf9 cell line, improved transfection reagent to faster generation of baculoviruses and expression enhancer that allow for consistent production of recombinant proteins with two-fold or greater improvements in protein titers compared to traditional BEVS workflows.
机译:杆状病毒表达载体系统(BEV)是重组蛋白质生产的主要平台之一,过去十年已成为疫苗发育的优选平台。与长期过渡到无血清化学定义的培养基的哺乳动物表达系统不同,在昆虫表达系统中发生了相对较少的创新,昆虫细胞继续依靠未定义的含酵母培养基,可以表现出显着的培养基 - 在细胞生长和蛋白质表达方面的批次变异。在这里,我们提出了一种基于高密度的新颖的基于的Sf9杆状病毒表达系统的发展,化学成分确定的培养基中,高表达的Sf9细胞系,改善的转染试剂以更快代杆状病毒和表达增强剂,其允许的与传统的FEVS工作流程相比,一致地生产具有两倍或更大的蛋白质滴度的改善或更大的改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号